Cardiology Today

CURRENTLY VIEWING:

The following articles appeared in the print edition of CARDIOLOGY TODAY.

Table of Contents
Commentary

REWIND: Assessing the role of dulaglutide for primary prevention of CVD

At Issue

At Issue: Lancet initiative sparks discussion on diversity in cardiology

Cover Story

New research, recent controversies question vitamin D benefits in CVD

FDA News

TAVR systems approved for low-risk patients

FDA advises clinicians to discuss risks of paclitaxel-coated devices with patients

In the Journals

MI probability, outcomes may be predicted with high-sensitivity troponin

Hormone therapy affects heart fat in women during menopause

High-risk patients unable to take PCSK9 inhibitors have poor outcomes

Guideline-based statin use, adherence higher with cardiologist care

Geographic region impacts high-intensity statin use after MI

Former NFL players at great risk for AF

Endovascular-first approach bests open surgery for amputation-free survival in CLI

Smoking cessation for 30 years confers reduced PAD risk similar to never smokers

Volanesorsen decreases triglycerides in familial chylomicronemia syndrome

Meeting News

SGLT2 inhibitors may have great potential in reducing HF in diabetes

Community-based mobile intervention improves CV health in black adults

Once-weekly exenatide reduces MACE risk in patients with type 2 diabetes, CVD

Preventive cardiology: Setting the stage for integration of lipids, diabetes and the heart

Pharmacology Consult

Synthetic marijuana poses risk for cardiotoxicity

Michael J. Scalese, PharmD, BCCP, BCPS, CACP

Trial Scorecards

RIPPAF

LATERAL

QDOT-FAST

CRIC

BASEL IX

APPROACH

RIKADA

APACE